Literature DB >> 11287975

Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor.

H Joensuu1, P J Roberts, M Sarlomo-Rikala, L C Andersson, P Tervahartiala, D Tuveson, S Silberman, R Capdeville, S Dimitrijevic, B Druker, G D Demetri.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11287975     DOI： 10.1056/NEJM200104053441404

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  432 in total

Review 1.  Molecular basis and management of gastrointestinal stromal tumors.

Authors:  Ulas D Bayraktar; Soley Bayraktar; Caio M Rocha-Lima
Journal:  World J Gastroenterol       Date:  2010-06-14       Impact factor: 5.742

Review 2.  Gastrointestinal stromal tumors: morphological, immunohistochemical and molecular changes associated with kinase inhibitor therapy.

Authors:  Mario Díaz Delgado; Alicia Hernández Amate; Sofía Pereira Gallardo; Sara Jaramillo; Juan Antonio Virizuela Echaburu; Ricardo J González-Cámpora
Journal:  Pathol Oncol Res       Date:  2011-01-29       Impact factor: 3.201

3.  KIT gene mutations in gastrointestinal stromal tumors: more complex than previously recognized?

Authors:  Jonathan A Fletcher; Christopher D M Fletcher; Brian P Rubin; Leonie K Ashman; Christopher L Corless; Michael C Heinrich
Journal:  Am J Pathol       Date:  2002-08       Impact factor: 4.307

4.  Tissue microarrays for predictive molecular pathology.

Authors:  G Sauter; M Mirlacher
Journal:  J Clin Pathol       Date:  2002-08       Impact factor: 3.411

5.  Soft-tissue images. Proximal jejunal gastrointestinal stromal tumour.

Authors:  Michael Cooke; Michael Dunham; Francis Sutherland
Journal:  Can J Surg       Date:  2003-04       Impact factor: 2.089

6.  Translational research: current status, challenges and future strategies.

Authors:  Dale Yu
Journal:  Am J Transl Res       Date:  2011-09-12       Impact factor: 4.060

7.  Increased KIT inhibition enhances therapeutic efficacy in gastrointestinal stromal tumor.

Authors:  Teresa S Kim; Michael J Cavnar; Noah A Cohen; Eric C Sorenson; Jonathan B Greer; Adrian M Seifert; Megan H Crawley; Benjamin L Green; Rachel Popow; Nagavarakishore Pillarsetty; Darren R Veach; Anson T Ku; Ferdinand Rossi; Peter Besmer; Cristina R Antonescu; Shan Zeng; Ronald P Dematteo
Journal:  Clin Cancer Res       Date:  2014-02-28       Impact factor: 12.531

8.  Expression of Ets-1 proto-oncoprotein in gastrointestinal stromal tumors, leiomyomas and schwannomas.

Authors:  Toshiyuki Nakayama; Ayumi Yoshizaki; Shinji Naito; Chun-Yang Wen; Gabit Alipov; Yuichi Yakata; Ichiro Sekine
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

9.  Role of Ki-67 as a prognostic factor in gastrointestinal stromal tumors.

Authors:  Borislav Belev; Iva Brčić; Juraj Prejac; Zrna Antunac Golubić; Damir Vrbanec; Jadranka Božikov; Ivan Alerić; Marko Boban; Jasminka Jakić Razumović
Journal:  World J Gastroenterol       Date:  2013-01-28       Impact factor: 5.742

10.  Laparoscopic approaches to resection of suspected gastric gastrointestinal stromal tumors based on tumor location.

Authors:  A Privette; L McCahill; E Borrazzo; Richard M Single; R Zubarik
Journal:  Surg Endosc       Date:  2007-08-22       Impact factor: 4.584
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.